Bactana Corp.
Farmington
About Bactana Corp.
Bactana is a global development stage company at the forefront of identifying and isolating molecules expressed from commensal anaerobic bacteria found in an animal's microbiome. Bactana develops therapies for pets to treat metabolic conditions like prediabetes, diabetes, and other diseases while also developing sustainable products to reduce the use of antibiotics and natural resources during livestock production. It was founded in 2017 and is headquartered in Farmington, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2022)
- Website: bactana.com
- Phone: [email protected]
Industries & Categories
Agriculture, Animal Feed, Biotechnology, Chemical, Food and Beverage
Social Profiles
Canonical: https://fsome.com/organization/bactana-corp-57770 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.